SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-011936
Filing Date
2024-02-07
Accepted
2024-02-07 06:10:12
Documents
12
Period of Report
2024-02-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K srzn-20240201.htm   iXBRL 8-K 39100
  Complete submission text file 0000950170-24-011936.txt   187408

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT srzn-20240201.xsd EX-101.SCH 46157
14 EXTRACTED XBRL INSTANCE DOCUMENT srzn-20240201_htm.xml XML 6600
Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Filer) CIK: 0001824893 (see all company filings)

IRS No.: 301374889 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39635 | Film No.: 24602011
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)